Detlef Balschun

Detlef Balschun

Auto-generated profile, based on publicly available information

Detlef Balschun

Brain and Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2019 in Science
Verified
Journal Article
Closed access
PDF file
HRHeather C. Rice
Heather C. Rice
DMDaniel de Malmazet
Daniel de Malmazet
ASAn Schreurs
An Schreurs
SFSamuel Frere
Samuel Frere
IMInge Van Molle
Inge Van Molle
JWJoris de Wit
Joris de Wit
A physiological function for sAPP?: Although the pathological role of the amyloid-β precursor protein (APP) in Alzheimer's disease is well studied, the physiological role of this protein has remained elusive. Rice et al. found that the secreted ectodomain of APP (sAPP) binds to GABA B R1a, the metabotropic receptor for the inhibitory neurotransmitter γ-aminobutyric acid (GABA) (see the Perspective by Korte). Binding suppressed synaptic vesicle release and modulated synaptic transmission and plasticity in mice. A short, 17–amino acid peptide in APP bound to GABA B R1a's sushi 1 domain, conferring structure to this unstructured domain. Therapeutics targeting this interaction could potentially benefit a range of neurological disorders in which GABA signaling is implicated. Science , this issue p. eaao4827 ; see also p. 123

1 November 2014 in Neurobiology of Aging
Verified
Journal Article
Closed access
TATariq Ahmed
Tariq Ahmed
AJAnn Van der Jeugd
Ann Van der Jeugd
DBDavid Blum
David Blum
MGMarie-Christine Galas
Marie-Christine Galas
RDRudi D’hooge
Rudi D’hooge
DBDetlef Balschun
Detlef Balschun

1 April 2017 in Neuropharmacology
Verified
Journal Article
Closed access
VSVictor Sabanov
Victor Sabanov
SBSien Braat
Sien Braat
LDLaura D'ANdrea
Laura D'ANdrea
Rob WillemsenRob Willemsen
Rob Willemsen
SZShimriet Zeidler
Shimriet Zeidler
DBDetlef Balschun
Detlef Balschun

24 August 2020 in Alzheimer's Research & Therapy
Verified
Journal Article
Open access
PDF file
ALAmira Latif-Hernandez
Amira Latif-Hernandez
VSVictor Sabanov
Victor Sabanov
TATariq Ahmed
Tariq Ahmed
KCKatleen Craessaerts
Katleen Craessaerts
TSTakashi Saito
Takashi Saito
DBDetlef Balschun
Detlef Balschun
Background: Intensive basic and preclinical research into Alzheimer’s disease (AD) has yielded important new findings, but they could not yet been translated into effective therapies. One of the reasons is the lack of animal models that sufficiently reproduce the complexity of human AD and the response of human brain circuits to novel treatment approaches. As a step in overcoming these limitations, new App knock-in models have been developed that avoid transgenic APP overexpression and its associated side effects. These mice are proposed to serve as valuable models to examine Aß-related pathology in “preclinical AD.” Methods: Since AD as the most common form of dementia progresses into synaptic failure as a major cause of cognitive deficits, the detailed characterization of synaptic dysfunction in these new models is essential. Here, we addressed this by extracellular and whole-cell patch-clamp recordings in AppNL-G-F mice compared to AppNL animals which served as controls. Results: We found a beginning synaptic impairment (LTP deficit) at 3–4 months in the prefrontal cortex of AppNL-G-F mice that is further aggravated and extended to the hippocampus at 6–8 months. Measurements of miniature EPSCs and IPSCs point to a marked increase in excitatory and inhibitory presynaptic activity, the latter accompanied by a moderate increase in postsynaptic inhibitory function. Conclusions: Our data reveal a marked impairment of primarily postsynaptic processes at the level of synaptic plasticity but the dominance of a presumably compensatory presynaptic upregulation at the level of elementary miniature synaptic function.

6 December 2019 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
CSCeline Samaey
Celine Samaey
ASAn Schreurs
An Schreurs
SSStijn Stroobants
Stijn Stroobants
DBDetlef Balschun
Detlef Balschun
Neurocognitive disorders, among which Alzheimer’s disease (AD), have become one of the major causes of death in developed countries. No effective disease-modifying therapy is available, possibly because current treatments are administered too late to still be able to intervene in the disease progress. AD is characterized by a gradual onset with subclinical neurobiological and behavioral changes that precede diagnosis with years to even decades. The earlier the diagnosis, the earlier potential treatments can be tested and started. Mouse models are valuable to study the possible causes underlying early phases of neuropathology and their reflection in behavior and other biomarkers, to help improve preclinical detection and diagnosis of AD. Here, we assessed cognitive functioning and social behavior in transgenic mice expressing tau pathology only (Tau-P301L) or a combination of amyloid and tau pathology [amyloid precursor protein (APP)-V717I × Tau-P301L]. The mice were subjected to a variety of behavioral tasks at an age of 3–6 months, i.e., at an early phase of their AD-like pathology. We hypothesized that compared to age-matched wild-type controls, transgenic mice would show specific impairments in both cognitive and non-cognitive tasks. In line with our expectations, transgenic mice showed decreased cognitive flexibility in the Morris water maze, decreased exploratory behavior, decreased performance in a nesting task, and increased anxiety-like behavior. In accordance with the amyloid-cascade hypothesis, some of the behavioral measures showed more severe deficits in APP-V717I × Tau-P301L compared to Tau-P301L mice, indicating an exacerbation of disease processes due to the co-occurrence of amyloid and tau pathology. Our study supports the use of behavioral markers as early indicators of ongoing AD pathology during the preclinical phase.

11 July 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ASAn Schreurs
An Schreurs
VSVictor Sabanov
Victor Sabanov
DBDetlef Balschun
Detlef Balschun
The hippocampus is important for spatial navigation, episodic memory and affective behaviour. Increasing evidence suggests that these multiple functions are accomplished by different segments along the dorsal-ventral (septal-temporal) axis. Long-term potentiation (LTP), the best-investigated cellular correlate of learning and memory, has distinct properties along this axis in the CA1 region, but so far, little is known about longitudinal differences in dentate gyrus (DG). Therefore, here we examined potential dorsoventral differences in DG-LTP usingin vitromulti-electrode array recordings. In young mice, we found higher basal synaptic transmission in the dorsal DG, while the LTP magnitude markedly increased towards the ventral pole. Strikingly, these differences were greatly reduced in slices from middle-aged mice. Short-term plasticity, evaluated by paired-pulse ratios, was similar across groups. Recordings in the presence and absence of GABAA-receptor blocker picrotoxin suggested a higher inhibitory tone in the ventral DG of young mice, confirmed by an increased frequency of miniature inhibitory postsynaptic currents. Our findings support the view that the hippocampus contains discrete functional domains along its dorsoventral axis and demonstrate that these are subject to age-dependent changes. Since these characteristics are presumably conserved in the human hippocampus, our findings have important clinical implications for hippocampus- and age-related disorders.